This inventor holds 1 USPTO granted patent. Top assignees: Kissei Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd.. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 176 
1 out of 575 Years Active: 1986
Title: Mitsuo Watanabe: Innovator in Pharmaceutical Chemistry
Introduction
Mitsuo Watanabe is a notable inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on imidazole derivatives.
Latest Patents
Watanabe holds a patent for 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate. This compound exhibits a strong and specific inhibitory effect on thromboxane synthetase from human or bovine platelet microsomes. It is recognized for its potential therapeutic applications in treating inflammation, hypertension, thrombus, cerebral apoplexy, and asthma. He has 1 patent to his name.
Career Highlights
Throughout his career, Watanabe has worked with prominent companies in the pharmaceutical industry. He has been associated with Kissei Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. His work has significantly impacted the development of new therapeutic agents.
Collaborations
Watanabe has collaborated with esteemed colleagues such as Shigeo Arikawa and Kaname Morita. Their combined expertise has contributed to advancements in pharmaceutical research.
Conclusion
Mitsuo Watanabe's innovative work in pharmaceutical chemistry has led to important developments in therapeutic agents. His contributions continue to influence the field and offer potential solutions for various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile